Cargando…

3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice

Previous studies have shown that accumulation of advanced glycation end products (AGEs) can be the cause of diabetic nephropathy (DN) in diabetic patients. Dihydrochalcone 3′-O-β-d-glucopyranosyl α,4,2′,4′,6′-pentahydroxy–dihydrochalcone (1) is a powerful antiglycation compound previously isolated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez Gutierrez, Rosa Martha, García Campoy, Abraham Heriberto, Paredes Carrera, Silvia Patricia, Muñiz Ramirez, Alethia, Mota Flores, José Maria, Flores Valle, Sergio Odin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480600/
https://www.ncbi.nlm.nih.gov/pubmed/30925713
http://dx.doi.org/10.3390/molecules24071214
_version_ 1783413602662744064
author Pérez Gutierrez, Rosa Martha
García Campoy, Abraham Heriberto
Paredes Carrera, Silvia Patricia
Muñiz Ramirez, Alethia
Mota Flores, José Maria
Flores Valle, Sergio Odin
author_facet Pérez Gutierrez, Rosa Martha
García Campoy, Abraham Heriberto
Paredes Carrera, Silvia Patricia
Muñiz Ramirez, Alethia
Mota Flores, José Maria
Flores Valle, Sergio Odin
author_sort Pérez Gutierrez, Rosa Martha
collection PubMed
description Previous studies have shown that accumulation of advanced glycation end products (AGEs) can be the cause of diabetic nephropathy (DN) in diabetic patients. Dihydrochalcone 3′-O-β-d-glucopyranosyl α,4,2′,4′,6′-pentahydroxy–dihydrochalcone (1) is a powerful antiglycation compound previously isolated from Eysenhardtia polystachya. The aim was to investigate whether (1) was able to protect against diabetic nephropathy in streptozotocin (STZ)-induced diabetic mice, which displayed renal dysfunction markers such as body weight, creatinine, uric acid, serum urea, total urinary protein, and urea nitrogen in the blood (BUN). In addition, pathological changes were evaluated including glycated hemoglobin (HbA1c), advanced glycation end products (AGEs) in the kidney, as well as in circulation level and pro-inflammatory markers ICAM-1 levels in diabetic mice. After 5 weeks, these elevated markers of dihydrochalcone treatment (25, 50 and 100 mg/kg) were significantly (p < 0.05) attenuated. In addition, they ameliorate the indices of renal inflammation as indicated by ICAM-1 markers. The kidney and circulatory AGEs levels in diabetic mice were significantly (p < 0.05) attenuated by (1) treatment. Histological analysis of kidney tissues showed an important recovery in its structure compared with the diabetic group. It was found that the compound (1) attenuated the renal damage in diabetic mice by inhibiting AGEs formation.
format Online
Article
Text
id pubmed-6480600
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64806002019-04-30 3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice Pérez Gutierrez, Rosa Martha García Campoy, Abraham Heriberto Paredes Carrera, Silvia Patricia Muñiz Ramirez, Alethia Mota Flores, José Maria Flores Valle, Sergio Odin Molecules Article Previous studies have shown that accumulation of advanced glycation end products (AGEs) can be the cause of diabetic nephropathy (DN) in diabetic patients. Dihydrochalcone 3′-O-β-d-glucopyranosyl α,4,2′,4′,6′-pentahydroxy–dihydrochalcone (1) is a powerful antiglycation compound previously isolated from Eysenhardtia polystachya. The aim was to investigate whether (1) was able to protect against diabetic nephropathy in streptozotocin (STZ)-induced diabetic mice, which displayed renal dysfunction markers such as body weight, creatinine, uric acid, serum urea, total urinary protein, and urea nitrogen in the blood (BUN). In addition, pathological changes were evaluated including glycated hemoglobin (HbA1c), advanced glycation end products (AGEs) in the kidney, as well as in circulation level and pro-inflammatory markers ICAM-1 levels in diabetic mice. After 5 weeks, these elevated markers of dihydrochalcone treatment (25, 50 and 100 mg/kg) were significantly (p < 0.05) attenuated. In addition, they ameliorate the indices of renal inflammation as indicated by ICAM-1 markers. The kidney and circulatory AGEs levels in diabetic mice were significantly (p < 0.05) attenuated by (1) treatment. Histological analysis of kidney tissues showed an important recovery in its structure compared with the diabetic group. It was found that the compound (1) attenuated the renal damage in diabetic mice by inhibiting AGEs formation. MDPI 2019-03-28 /pmc/articles/PMC6480600/ /pubmed/30925713 http://dx.doi.org/10.3390/molecules24071214 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pérez Gutierrez, Rosa Martha
García Campoy, Abraham Heriberto
Paredes Carrera, Silvia Patricia
Muñiz Ramirez, Alethia
Mota Flores, José Maria
Flores Valle, Sergio Odin
3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice
title 3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice
title_full 3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice
title_fullStr 3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice
title_full_unstemmed 3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice
title_short 3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice
title_sort 3′-o-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from bark of eysenhardtia polystachya prevents diabetic nephropathy via inhibiting protein glycation in stz-nicotinamide induced diabetic mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480600/
https://www.ncbi.nlm.nih.gov/pubmed/30925713
http://dx.doi.org/10.3390/molecules24071214
work_keys_str_mv AT perezgutierrezrosamartha 3obdglucopyranosyla4246pentahydroxydihydrochalconefrombarkofeysenhardtiapolystachyapreventsdiabeticnephropathyviainhibitingproteinglycationinstznicotinamideinduceddiabeticmice
AT garciacampoyabrahamheriberto 3obdglucopyranosyla4246pentahydroxydihydrochalconefrombarkofeysenhardtiapolystachyapreventsdiabeticnephropathyviainhibitingproteinglycationinstznicotinamideinduceddiabeticmice
AT paredescarrerasilviapatricia 3obdglucopyranosyla4246pentahydroxydihydrochalconefrombarkofeysenhardtiapolystachyapreventsdiabeticnephropathyviainhibitingproteinglycationinstznicotinamideinduceddiabeticmice
AT munizramirezalethia 3obdglucopyranosyla4246pentahydroxydihydrochalconefrombarkofeysenhardtiapolystachyapreventsdiabeticnephropathyviainhibitingproteinglycationinstznicotinamideinduceddiabeticmice
AT motafloresjosemaria 3obdglucopyranosyla4246pentahydroxydihydrochalconefrombarkofeysenhardtiapolystachyapreventsdiabeticnephropathyviainhibitingproteinglycationinstznicotinamideinduceddiabeticmice
AT floresvallesergioodin 3obdglucopyranosyla4246pentahydroxydihydrochalconefrombarkofeysenhardtiapolystachyapreventsdiabeticnephropathyviainhibitingproteinglycationinstznicotinamideinduceddiabeticmice